This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …

find that prices have a negative impact on transitions in the sense that an increase in the brand price will reduce the … transition from generics to brand and likewise an increase in the generic price will reduce the transition from brand to generics …

natural policy experiment in Norway, to what extent the price responsiveness of prescription choices is affected when the … structural model for the three drugs, covering demand and price setting, is estimated in a joint maximum likelihood approach. We … national insurance. -- pharmaceuticals ; discrete choice model ; funding-schemes …

explains large price heterogeneities across buyers, drug classes, and time periods. Additionally, of the drug price variation … transaction volume, buyer's loyalty, and multiple drug purchases strengthens buyer's bargaining power and results in a drug price …

We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical …), creating a captive and a selective segment of physicians. First, we show that detailing, DTCA and price (if not regulated) are …/or price regulation is lenient. The desirability of DTCA also depends on whether or not the regulator is concerned with firms …